Nantahala Capital Management, LLC Abeona Therapeutics Inc. Call Options Transaction History

Nantahala Capital Management, LLC

  • $1.5 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$3.71 - $5.14 $1.74 Million - $2.41 Million
468,000 Added 900.0%
520,000 $2.61 Million
Q3 2023

Nov 14, 2023
BUY
$2.98 - $4.43 $95,360 - $141,760
32,000 Added 160.0%
52,000 $218,000
Q2 2023

Aug 14, 2023
BUY
$2.76 - $5.27 $55,199 - $105,399
20,000 New
20,000 $80,000

Others Institutions Holding ABEO

# of Institutions
57
Shares Held
28.6M
Call Options Held
827K
Put Options Held
44.5K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $38.1M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email